EU HTA – Achieving broad access fast! What will it take for innovative medicines to succeed?
Watch the recording of our panel discussion hosted by Evidence Base and discover the essential healthcare system requirements and policies crucial for accelerating patient access to groundbreaking medicines.
Moderator
Speaker
Speaker
François Meyer
Independent Consultant
Speaker
What will you learn?
- Critical success factors for the EU HTA Regulation implementation
- Strategies to leverage JCA reports while ensuring broad patient access across Europe
- Recommendations for collaboration among member states, healthcare systems, and industry stakeholders
- How the new JCA will impact healthcare delivery and innovation
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.